Literature DB >> 32409005

Rare causes of hypoglycemia in adults.

Claire Douillard1, Arnaud Jannin2, Marie-Christine Vantyghem3.   

Abstract

Hypoglycemia is defined by a low blood glucose level associated to clinical symptoms. Hypoglycemia may be related to treatment of diabetes, but also to drugs, alcohol, critical illness, cortisol insufficiency including hypopituitarism, insulinoma, bariatric or gastric surgery, pancreas transplantation or glucagon deficiency, or may be surreptitious. Some hypoglycemic episodes remain unexplained, and genetic, paraneoplastic and immune causes should be considered. Genetic causes may be related to endogenous hyperinsulinism and to inborn errors of metabolism (IEM). Endogenous hyperinsulinism is related to monogenic congenital hyperinsulinism, and especially to mutations of the glucokinase-activating gene or of insulin receptors, both characterised by postprandial hypoglycemia with major hyperinsulinism. In adulthood, IEM-related hypoglycemia can persist in a previously diagnosed childhood disease or may be a presenting sign. It is suggested by systemic involvement (rhabdomyolysis after fasting or exercising, heart disease, hepatomegaly), sometimes associated to a family history of hypoglycemia. The timing of hypoglycemic episodes with respect to the last meal also helps to orientate diagnosis. Fasting hypoglycemia may be related to type 0, I or III glycogen synthesis disorder, fatty acid oxidation or gluconeogenesis disorder. Postprandial hypoglycemia may be related to inherited fructose intolerance. Exercise-induced hyperinsulinism is mainly related to activating mutation of the SLC16A1 gene. Besides exceptional ectopic insulin secretion, paraneoplastic causes involve NICTH (Non-Islet-Cell Tumour Hypoglycemia), caused by Big-IGF2 secretion by a large tumour, with low blood levels of insulin, C-peptide and IGF1. Autoimmune causes involve antibodies against insulin (HIRATA syndrome), especially in case of Graves' disease, or against the insulin receptor. Medical history, timing, and insulin level orientate the diagnosis.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Anti-insulin receptor and insulin antibodies; Beta-oxidation disorders; Erreur métabolique innée; Glucokinase mutation; Glycogen synthesis disorder; HIRATA syndrome; Hereditary fructose intolerance; Hypoglycemia; Hypoglycémie; IGF2; Inborn errors of metabolism; Insulin receptor mutation; Insulinorésistance de type B; Intolérance héréditaire au fructose; Mutation de la glucokinase; Mutation du récepteur de l’insuline; NICTH; Neoglucogenesis disorders; Récepteur anti-insuline et anticorps anti-insuline; Syndrome HIRATA; Trouble de la synthèse du glycogène; Troubles de la beta-oxydation; Troubles de la néoglucogenèse; Type B insulin resistance

Mesh:

Substances:

Year:  2020        PMID: 32409005     DOI: 10.1016/j.ando.2020.04.003

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   3.117


  3 in total

1.  Identification of Reactive Hypoglycemia with Different Basic BMI and Its Causes by Prolonged Oral Glucose Tolerance Test.

Authors:  Xue Lv; Kun Fang; Wenqing Hao; Yuxin Han; Nailong Yang; Qing Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-02       Impact factor: 3.168

2.  Accumulation of acetaldehyde in aldh2.1-/- zebrafish causes increased retinal angiogenesis and impaired glucose metabolism.

Authors:  David Philipp Wohlfart; Bowen Lou; Chiara Simone Middel; Jakob Morgenstern; Thomas Fleming; Carsten Sticht; Ingrid Hausser; Rüdiger Hell; Hans-Peter Hammes; Julia Szendrödi; Peter Paul Nawroth; Jens Kroll
Journal:  Redox Biol       Date:  2022-01-26       Impact factor: 11.799

3.  Insulin at 100 years - is rebalancing its action key to fighting obesity-related disease?

Authors:  Gemma V Brierley; Robert K Semple
Journal:  Dis Model Mech       Date:  2021-11-29       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.